| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hydrocephalus | 49 | 2025 | 276 | 7.590 |
Why?
|
| Fecal Incontinence | 38 | 2025 | 78 | 6.960 |
Why?
|
| Meningomyelocele | 34 | 2025 | 255 | 4.370 |
Why?
|
| Cerebrospinal Fluid Shunts | 31 | 2025 | 95 | 4.220 |
Why?
|
| Irritable Bowel Syndrome | 22 | 2025 | 222 | 4.150 |
Why?
|
| Fetoscopy | 35 | 2025 | 448 | 3.410 |
Why?
|
| Biofeedback, Psychology | 23 | 2024 | 39 | 2.970 |
Why?
|
| Constipation | 22 | 2024 | 126 | 2.850 |
Why?
|
| Gastrointestinal Diseases | 18 | 2023 | 360 | 2.440 |
Why?
|
| Neurosurgical Procedures | 25 | 2024 | 317 | 2.420 |
Why?
|
| Neural Tube Defects | 19 | 2024 | 358 | 2.340 |
Why?
|
| Quality of Life | 36 | 2025 | 2149 | 2.300 |
Why?
|
| Ventriculoperitoneal Shunt | 14 | 2025 | 58 | 1.870 |
Why?
|
| Spinal Dysraphism | 12 | 2024 | 274 | 1.670 |
Why?
|
| Abdominal Pain | 12 | 2018 | 314 | 1.580 |
Why?
|
| Hysterotomy | 16 | 2025 | 127 | 1.570 |
Why?
|
| Spina Bifida Cystica | 5 | 2024 | 35 | 1.500 |
Why?
|
| Female | 239 | 2025 | 71644 | 1.490 |
Why?
|
| Humans | 308 | 2025 | 133748 | 1.410 |
Why?
|
| Ventriculostomy | 13 | 2024 | 44 | 1.400 |
Why?
|
| Surveys and Questionnaires | 41 | 2025 | 3986 | 1.320 |
Why?
|
| Third Ventricle | 10 | 2024 | 33 | 1.220 |
Why?
|
| Anal Canal | 17 | 2023 | 82 | 1.200 |
Why?
|
| Male | 161 | 2025 | 65884 | 1.090 |
Why?
|
| Spinal Fusion | 13 | 2024 | 114 | 1.080 |
Why?
|
| Adult | 98 | 2025 | 31892 | 1.040 |
Why?
|
| Proton Therapy | 8 | 2023 | 151 | 1.040 |
Why?
|
| Treatment Outcome | 71 | 2025 | 13007 | 1.030 |
Why?
|
| Exercise Therapy | 5 | 2021 | 182 | 1.030 |
Why?
|
| Child | 100 | 2025 | 25780 | 0.980 |
Why?
|
| Equipment Failure | 8 | 2025 | 133 | 0.970 |
Why?
|
| Rectal Diseases | 5 | 2021 | 21 | 0.960 |
Why?
|
| Neuroendoscopy | 11 | 2024 | 31 | 0.950 |
Why?
|
| Arnold-Chiari Malformation | 5 | 2024 | 51 | 0.950 |
Why?
|
| Pregnancy | 50 | 2025 | 7545 | 0.940 |
Why?
|
| Retrospective Studies | 72 | 2025 | 17433 | 0.930 |
Why?
|
| Infant, Newborn | 50 | 2025 | 8592 | 0.920 |
Why?
|
| Child, Preschool | 67 | 2025 | 14810 | 0.920 |
Why?
|
| Manometry | 13 | 2024 | 73 | 0.900 |
Why?
|
| Infant | 64 | 2025 | 13175 | 0.890 |
Why?
|
| Catheters, Indwelling | 4 | 2021 | 157 | 0.870 |
Why?
|
| Dyspepsia | 5 | 2025 | 108 | 0.870 |
Why?
|
| Prevalence | 22 | 2025 | 2668 | 0.860 |
Why?
|
| Prospective Studies | 40 | 2025 | 6592 | 0.860 |
Why?
|
| Fetal Diseases | 8 | 2025 | 462 | 0.850 |
Why?
|
| Pelvic Floor | 7 | 2014 | 37 | 0.840 |
Why?
|
| Foreign-Body Migration | 2 | 2014 | 61 | 0.840 |
Why?
|
| Colonic Diseases, Functional | 13 | 2007 | 26 | 0.840 |
Why?
|
| Adaptation, Psychological | 9 | 2024 | 449 | 0.820 |
Why?
|
| Stress, Psychological | 8 | 2017 | 601 | 0.820 |
Why?
|
| Cerebellar Neoplasms | 8 | 2024 | 459 | 0.820 |
Why?
|
| Adolescent | 77 | 2025 | 20541 | 0.800 |
Why?
|
| Cervical Vertebrae | 10 | 2024 | 118 | 0.790 |
Why?
|
| Postoperative Complications | 22 | 2025 | 3162 | 0.790 |
Why?
|
| Research Design | 5 | 2018 | 747 | 0.760 |
Why?
|
| Cerebral Ventricles | 4 | 2024 | 84 | 0.760 |
Why?
|
| Medulloblastoma | 7 | 2024 | 568 | 0.740 |
Why?
|
| Decision Support Techniques | 4 | 2023 | 319 | 0.730 |
Why?
|
| Cerebral Hemorrhage | 7 | 2025 | 154 | 0.720 |
Why?
|
| Echoencephalography | 2 | 2013 | 26 | 0.710 |
Why?
|
| Pituitary Neoplasms | 4 | 2023 | 85 | 0.710 |
Why?
|
| Defecation | 8 | 2024 | 34 | 0.700 |
Why?
|
| Brain | 11 | 2024 | 3226 | 0.690 |
Why?
|
| Reoperation | 15 | 2025 | 852 | 0.680 |
Why?
|
| Severity of Illness Index | 20 | 2021 | 3098 | 0.670 |
Why?
|
| Practice Patterns, Physicians' | 3 | 2018 | 769 | 0.650 |
Why?
|
| Global Health | 5 | 2025 | 620 | 0.650 |
Why?
|
| Child Behavior | 3 | 2015 | 234 | 0.650 |
Why?
|
| Fetus | 9 | 2024 | 599 | 0.640 |
Why?
|
| Anus Diseases | 4 | 2014 | 14 | 0.630 |
Why?
|
| Diarrhea | 6 | 2020 | 342 | 0.630 |
Why?
|
| Dietary Fiber | 4 | 2018 | 83 | 0.630 |
Why?
|
| Middle Aged | 58 | 2025 | 29314 | 0.610 |
Why?
|
| Cohort Studies | 30 | 2025 | 5194 | 0.610 |
Why?
|
| Obstetric Labor Complications | 4 | 2018 | 97 | 0.610 |
Why?
|
| Brain Neoplasms | 10 | 2024 | 1407 | 0.600 |
Why?
|
| Urinary Incontinence | 10 | 2018 | 77 | 0.590 |
Why?
|
| Magnetic Resonance Imaging | 28 | 2024 | 3845 | 0.580 |
Why?
|
| Gestational Age | 15 | 2024 | 1225 | 0.580 |
Why?
|
| Chordoma | 3 | 2024 | 23 | 0.570 |
Why?
|
| Aged | 51 | 2025 | 21687 | 0.570 |
Why?
|
| Syringomyelia | 3 | 2024 | 18 | 0.570 |
Why?
|
| Catheters | 4 | 2023 | 89 | 0.560 |
Why?
|
| Uterine Prolapse | 5 | 2008 | 20 | 0.560 |
Why?
|
| Anesthesia, Closed-Circuit | 1 | 2017 | 2 | 0.560 |
Why?
|
| Rectum | 8 | 2021 | 113 | 0.560 |
Why?
|
| United States | 29 | 2023 | 11714 | 0.560 |
Why?
|
| Choroid Plexus | 5 | 2021 | 24 | 0.550 |
Why?
|
| Phenylephrine | 1 | 2017 | 39 | 0.550 |
Why?
|
| Bone Screws | 7 | 2011 | 53 | 0.550 |
Why?
|
| Drug Therapy, Computer-Assisted | 1 | 2017 | 51 | 0.530 |
Why?
|
| Risk Factors | 31 | 2022 | 11122 | 0.530 |
Why?
|
| Vasoconstrictor Agents | 1 | 2017 | 146 | 0.510 |
Why?
|
| Mother-Child Relations | 2 | 2015 | 79 | 0.500 |
Why?
|
| Child Development | 4 | 2025 | 286 | 0.500 |
Why?
|
| Endoscopy | 4 | 2019 | 287 | 0.490 |
Why?
|
| Premature Birth | 5 | 2023 | 417 | 0.490 |
Why?
|
| Young Adult | 30 | 2025 | 9883 | 0.480 |
Why?
|
| Behavior Therapy | 5 | 2009 | 268 | 0.480 |
Why?
|
| Surgical Wound Infection | 5 | 2022 | 275 | 0.480 |
Why?
|
| Pain Measurement | 10 | 2018 | 368 | 0.470 |
Why?
|
| Decompression, Surgical | 5 | 2024 | 90 | 0.460 |
Why?
|
| Catheter Obstruction | 3 | 2024 | 7 | 0.450 |
Why?
|
| Sick Role | 4 | 2006 | 32 | 0.450 |
Why?
|
| Delivery, Obstetric | 6 | 2021 | 259 | 0.450 |
Why?
|
| Adolescent Behavior | 2 | 2015 | 181 | 0.440 |
Why?
|
| Joint Instability | 5 | 2020 | 59 | 0.420 |
Why?
|
| Water Deprivation | 1 | 2013 | 4 | 0.420 |
Why?
|
| Drinking Behavior | 1 | 2013 | 9 | 0.420 |
Why?
|
| Skull Base Neoplasms | 2 | 2014 | 42 | 0.420 |
Why?
|
| Prenatal Care | 5 | 2023 | 359 | 0.410 |
Why?
|
| Central Nervous System Cysts | 1 | 2012 | 12 | 0.410 |
Why?
|
| Infant, Premature | 7 | 2025 | 858 | 0.400 |
Why?
|
| Ependymoma | 3 | 2023 | 175 | 0.400 |
Why?
|
| Nasal Septum | 1 | 2012 | 18 | 0.400 |
Why?
|
| Surgery, Computer-Assisted | 2 | 2016 | 64 | 0.400 |
Why?
|
| Sensation | 6 | 2021 | 58 | 0.400 |
Why?
|
| Parents | 5 | 2017 | 1068 | 0.390 |
Why?
|
| Walking | 3 | 2024 | 234 | 0.390 |
Why?
|
| Canada | 8 | 2021 | 346 | 0.390 |
Why?
|
| Plant Extracts | 1 | 2014 | 138 | 0.390 |
Why?
|
| Spinal Neoplasms | 4 | 2019 | 75 | 0.380 |
Why?
|
| Follow-Up Studies | 22 | 2024 | 5467 | 0.380 |
Why?
|
| Catastrophization | 3 | 2025 | 18 | 0.380 |
Why?
|
| United Kingdom | 7 | 2021 | 242 | 0.380 |
Why?
|
| Multivariate Analysis | 9 | 2018 | 1492 | 0.370 |
Why?
|
| Ultrasonography, Interventional | 1 | 2013 | 205 | 0.370 |
Why?
|
| Referral and Consultation | 2 | 2019 | 571 | 0.370 |
Why?
|
| Age Factors | 14 | 2021 | 2990 | 0.370 |
Why?
|
| Kyphosis | 5 | 2012 | 22 | 0.360 |
Why?
|
| Blood Pressure | 1 | 2017 | 1419 | 0.360 |
Why?
|
| Reproducibility of Results | 7 | 2023 | 3035 | 0.360 |
Why?
|
| Bacterial Infections | 4 | 2019 | 327 | 0.350 |
Why?
|
| Neuroimaging | 4 | 2020 | 374 | 0.350 |
Why?
|
| Nurses | 3 | 2022 | 75 | 0.350 |
Why?
|
| Urogenital Surgical Procedures | 2 | 2007 | 10 | 0.350 |
Why?
|
| Practice Guidelines as Topic | 2 | 2021 | 1337 | 0.350 |
Why?
|
| Surgical Flaps | 1 | 2012 | 196 | 0.350 |
Why?
|
| Radiotherapy, Intensity-Modulated | 3 | 2017 | 106 | 0.340 |
Why?
|
| Laparotomy | 4 | 2024 | 142 | 0.340 |
Why?
|
| Rome | 5 | 2023 | 10 | 0.330 |
Why?
|
| Patient Acceptance of Health Care | 4 | 2021 | 474 | 0.330 |
Why?
|
| Odontoid Process | 2 | 2024 | 10 | 0.330 |
Why?
|
| Colon | 5 | 1995 | 379 | 0.320 |
Why?
|
| Ehlers-Danlos Syndrome | 2 | 2020 | 53 | 0.320 |
Why?
|
| Cerebrospinal Fluid | 3 | 2020 | 99 | 0.320 |
Why?
|
| Urinary Bladder Diseases | 2 | 2021 | 34 | 0.310 |
Why?
|
| Magnesium Sulfate | 2 | 2021 | 50 | 0.310 |
Why?
|
| Anti-Bacterial Agents | 8 | 2022 | 2569 | 0.310 |
Why?
|
| Scoliosis | 5 | 2022 | 142 | 0.310 |
Why?
|
| Nursing Homes | 1 | 2010 | 107 | 0.310 |
Why?
|
| Motor Activity | 3 | 2021 | 539 | 0.310 |
Why?
|
| Hypothermia | 2 | 2021 | 61 | 0.310 |
Why?
|
| Craniopharyngioma | 2 | 2023 | 35 | 0.310 |
Why?
|
| Neurodevelopmental Disorders | 2 | 2025 | 530 | 0.310 |
Why?
|
| Geriatric Assessment | 1 | 2010 | 188 | 0.310 |
Why?
|
| Hydrothorax | 1 | 2008 | 11 | 0.310 |
Why?
|
| Antidiarrheals | 3 | 2019 | 18 | 0.300 |
Why?
|
| Clinical Decision-Making | 4 | 2019 | 296 | 0.300 |
Why?
|
| Radiography | 14 | 2015 | 825 | 0.300 |
Why?
|
| Atlanto-Occipital Joint | 2 | 2024 | 6 | 0.300 |
Why?
|
| Cervical Atlas | 2 | 2024 | 7 | 0.300 |
Why?
|
| Chronic Pain | 2 | 2021 | 149 | 0.300 |
Why?
|
| Tomography, X-Ray Computed | 16 | 2021 | 2174 | 0.300 |
Why?
|
| Anxiety | 5 | 2017 | 991 | 0.300 |
Why?
|
| Spine | 5 | 2012 | 147 | 0.300 |
Why?
|
| Rectocele | 2 | 2008 | 2 | 0.290 |
Why?
|
| Kaplan-Meier Estimate | 6 | 2020 | 1145 | 0.290 |
Why?
|
| Neurosurgery | 3 | 2024 | 78 | 0.290 |
Why?
|
| Gastrointestinal Motility | 4 | 1993 | 56 | 0.290 |
Why?
|
| Loperamide | 2 | 2019 | 8 | 0.280 |
Why?
|
| Ataxia | 2 | 2023 | 177 | 0.280 |
Why?
|
| Gastroenterology | 2 | 2019 | 210 | 0.280 |
Why?
|
| Lumbar Vertebrae | 4 | 2011 | 118 | 0.280 |
Why?
|
| Electromyography | 6 | 2009 | 178 | 0.270 |
Why?
|
| Health Surveys | 7 | 2020 | 262 | 0.270 |
Why?
|
| Catheterization | 2 | 2007 | 238 | 0.270 |
Why?
|
| Feeding Behavior | 1 | 2013 | 731 | 0.270 |
Why?
|
| Child Abuse | 1 | 2010 | 203 | 0.270 |
Why?
|
| Skull Base | 3 | 2024 | 52 | 0.270 |
Why?
|
| Registries | 7 | 2025 | 1571 | 0.270 |
Why?
|
| Longitudinal Studies | 9 | 2021 | 1497 | 0.270 |
Why?
|
| Disability Evaluation | 5 | 2017 | 195 | 0.260 |
Why?
|
| Cross-Sectional Studies | 12 | 2025 | 3743 | 0.260 |
Why?
|
| Aged, 80 and over | 17 | 2023 | 7198 | 0.260 |
Why?
|
| Epidermal Cyst | 1 | 2006 | 18 | 0.250 |
Why?
|
| Pain Threshold | 3 | 2017 | 23 | 0.250 |
Why?
|
| Atlanto-Axial Joint | 3 | 2012 | 21 | 0.250 |
Why?
|
| Parent-Child Relations | 4 | 2013 | 253 | 0.250 |
Why?
|
| Intestinal Obstruction | 1 | 2007 | 97 | 0.250 |
Why?
|
| Infant, Premature, Diseases | 2 | 2021 | 254 | 0.240 |
Why?
|
| Chi-Square Distribution | 3 | 2014 | 606 | 0.240 |
Why?
|
| Proportional Hazards Models | 7 | 2018 | 1488 | 0.240 |
Why?
|
| Psyllium | 2 | 2015 | 13 | 0.240 |
Why?
|
| Cerebellar Diseases | 1 | 2006 | 81 | 0.240 |
Why?
|
| Prosthesis-Related Infections | 3 | 2017 | 186 | 0.240 |
Why?
|
| Carbon Dioxide | 4 | 2023 | 289 | 0.240 |
Why?
|
| Health Status | 3 | 2018 | 412 | 0.240 |
Why?
|
| Logistic Models | 7 | 2012 | 1908 | 0.240 |
Why?
|
| Predictive Value of Tests | 5 | 2020 | 2297 | 0.240 |
Why?
|
| Ultrasonography, Prenatal | 5 | 2024 | 1000 | 0.240 |
Why?
|
| Gastrointestinal Transit | 3 | 2014 | 27 | 0.230 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2021 | 1213 | 0.230 |
Why?
|
| Marriage | 1 | 2025 | 33 | 0.230 |
Why?
|
| Craniosynostoses | 2 | 2021 | 134 | 0.230 |
Why?
|
| Thoracic Vertebrae | 5 | 2012 | 69 | 0.230 |
Why?
|
| Body Mass Index | 4 | 2020 | 1715 | 0.230 |
Why?
|
| Time Factors | 12 | 2021 | 6583 | 0.220 |
Why?
|
| Growth Disorders | 1 | 2006 | 223 | 0.220 |
Why?
|
| Rhabdoid Tumor | 2 | 2018 | 56 | 0.220 |
Why?
|
| Anesthesia, Obstetrical | 1 | 2024 | 37 | 0.220 |
Why?
|
| Cerebrospinal Fluid Leak | 3 | 2021 | 45 | 0.220 |
Why?
|
| Illness Behavior | 2 | 2015 | 7 | 0.220 |
Why?
|
| Occipital Bone | 1 | 2024 | 20 | 0.220 |
Why?
|
| Craniotomy | 4 | 2021 | 106 | 0.220 |
Why?
|
| Crohn Disease | 2 | 2017 | 290 | 0.220 |
Why?
|
| Linear Models | 5 | 2016 | 722 | 0.220 |
Why?
|
| Mutism | 1 | 2024 | 32 | 0.210 |
Why?
|
| Guideline Adherence | 2 | 2017 | 399 | 0.210 |
Why?
|
| Sex Distribution | 4 | 2020 | 331 | 0.210 |
Why?
|
| Odds Ratio | 5 | 2018 | 1338 | 0.210 |
Why?
|
| Heart Rate, Fetal | 2 | 2021 | 63 | 0.210 |
Why?
|
| Bradycardia | 3 | 2021 | 63 | 0.210 |
Why?
|
| Ambulatory Care | 4 | 2011 | 415 | 0.210 |
Why?
|
| Malaysia | 3 | 2025 | 17 | 0.210 |
Why?
|
| Recurrence | 6 | 2023 | 1470 | 0.200 |
Why?
|
| Anesthesia, General | 3 | 2024 | 125 | 0.200 |
Why?
|
| Phaeohyphomycosis | 1 | 2022 | 10 | 0.200 |
Why?
|
| Glioma | 2 | 2021 | 538 | 0.200 |
Why?
|
| Cerebral Ventriculitis | 1 | 2022 | 15 | 0.200 |
Why?
|
| Medically Unexplained Symptoms | 1 | 2022 | 11 | 0.200 |
Why?
|
| Central Nervous System Infections | 1 | 2022 | 22 | 0.200 |
Why?
|
| Cysts | 1 | 2023 | 104 | 0.200 |
Why?
|
| Analysis of Variance | 5 | 2015 | 1044 | 0.200 |
Why?
|
| Clinical Protocols | 2 | 2015 | 245 | 0.190 |
Why?
|
| Pain | 3 | 2017 | 481 | 0.190 |
Why?
|
| Amnion | 2 | 2020 | 40 | 0.190 |
Why?
|
| Incidence | 8 | 2020 | 3408 | 0.190 |
Why?
|
| Cerebellar Vermis | 1 | 2022 | 4 | 0.190 |
Why?
|
| Cranial Sutures | 2 | 2012 | 33 | 0.190 |
Why?
|
| Corpus Callosum | 1 | 2022 | 104 | 0.190 |
Why?
|
| Intelligence | 2 | 2019 | 107 | 0.190 |
Why?
|
| Transition to Adult Care | 1 | 2024 | 119 | 0.190 |
Why?
|
| Monitoring, Physiologic | 2 | 2017 | 389 | 0.190 |
Why?
|
| Symptom Assessment | 3 | 2017 | 108 | 0.190 |
Why?
|
| Pregnancy Outcome | 3 | 2020 | 625 | 0.190 |
Why?
|
| Nervous System Malformations | 1 | 2023 | 131 | 0.190 |
Why?
|
| Dose-Response Relationship, Drug | 5 | 2021 | 1735 | 0.190 |
Why?
|
| Depression | 7 | 2017 | 1358 | 0.190 |
Why?
|
| Asia | 3 | 2017 | 126 | 0.190 |
Why?
|
| Survivorship | 1 | 2022 | 44 | 0.190 |
Why?
|
| Craniospinal Irradiation | 2 | 2019 | 66 | 0.190 |
Why?
|
| Nausea | 2 | 2018 | 87 | 0.190 |
Why?
|
| Cost-Benefit Analysis | 2 | 2021 | 562 | 0.180 |
Why?
|
| Inflammatory Bowel Diseases | 2 | 2016 | 326 | 0.180 |
Why?
|
| Ultrasonography | 3 | 2016 | 1004 | 0.180 |
Why?
|
| Transferrin | 1 | 2021 | 50 | 0.180 |
Why?
|
| Mechanical Thrombolysis | 1 | 2021 | 10 | 0.180 |
Why?
|
| Cerebrospinal Fluid Otorrhea | 1 | 2021 | 5 | 0.180 |
Why?
|
| Constriction, Pathologic | 2 | 2020 | 239 | 0.180 |
Why?
|
| CD56 Antigen | 1 | 2021 | 28 | 0.180 |
Why?
|
| Vomiting | 2 | 2018 | 110 | 0.180 |
Why?
|
| Tympanic Membrane | 1 | 2021 | 19 | 0.180 |
Why?
|
| Astrocytoma | 3 | 2013 | 113 | 0.180 |
Why?
|
| Rhombencephalon | 1 | 2021 | 50 | 0.180 |
Why?
|
| Dura Mater | 1 | 2021 | 26 | 0.180 |
Why?
|
| Machine Learning | 1 | 2024 | 334 | 0.180 |
Why?
|
| Ear, Inner | 1 | 2021 | 50 | 0.170 |
Why?
|
| Ferritins | 1 | 2021 | 109 | 0.170 |
Why?
|
| Sinus Thrombosis, Intracranial | 1 | 2021 | 48 | 0.170 |
Why?
|
| Fistula | 1 | 2021 | 53 | 0.170 |
Why?
|
| Fibromyalgia | 1 | 2020 | 21 | 0.170 |
Why?
|
| Cranial Fontanelles | 2 | 2012 | 4 | 0.170 |
Why?
|
| Prognosis | 6 | 2024 | 5073 | 0.170 |
Why?
|
| Brain Diseases | 1 | 2023 | 310 | 0.170 |
Why?
|
| Gadolinium | 1 | 2021 | 117 | 0.170 |
Why?
|
| Celiac Disease | 1 | 2021 | 73 | 0.170 |
Why?
|
| Factor Analysis, Statistical | 5 | 2023 | 233 | 0.170 |
Why?
|
| Postural Orthostatic Tachycardia Syndrome | 1 | 2020 | 12 | 0.170 |
Why?
|
| Clinical Competence | 3 | 2018 | 1058 | 0.170 |
Why?
|
| Wound Closure Techniques | 1 | 2020 | 28 | 0.170 |
Why?
|
| White Matter | 1 | 2022 | 210 | 0.170 |
Why?
|
| Biological Specimen Banks | 1 | 2020 | 54 | 0.170 |
Why?
|
| Neurosurgeons | 1 | 2020 | 15 | 0.170 |
Why?
|
| alpha-Fetoproteins | 1 | 2021 | 134 | 0.160 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 2020 | 57 | 0.160 |
Why?
|
| Mycobacterium abscessus | 1 | 2020 | 6 | 0.160 |
Why?
|
| Indomethacin | 1 | 2020 | 86 | 0.160 |
Why?
|
| Healthcare Disparities | 1 | 2025 | 478 | 0.160 |
Why?
|
| Fetal Membranes, Premature Rupture | 1 | 2020 | 62 | 0.160 |
Why?
|
| Infratentorial Neoplasms | 2 | 2010 | 48 | 0.160 |
Why?
|
| Microsurgery | 2 | 2011 | 65 | 0.160 |
Why?
|
| Mycobacterium Infections, Nontuberculous | 1 | 2020 | 44 | 0.160 |
Why?
|
| Ductus Arteriosus | 1 | 2020 | 61 | 0.160 |
Why?
|
| Computers | 2 | 2017 | 73 | 0.160 |
Why?
|
| Debridement | 1 | 2020 | 91 | 0.160 |
Why?
|
| Surgical Wound Dehiscence | 1 | 2019 | 51 | 0.160 |
Why?
|
| Photons | 1 | 2019 | 53 | 0.160 |
Why?
|
| Fibrinolytic Agents | 1 | 2021 | 203 | 0.160 |
Why?
|
| Language | 1 | 2021 | 221 | 0.160 |
Why?
|
| Hernia | 1 | 2019 | 18 | 0.160 |
Why?
|
| Sex Factors | 6 | 2017 | 1386 | 0.150 |
Why?
|
| Vagina | 2 | 2009 | 201 | 0.150 |
Why?
|
| Biomarkers, Tumor | 3 | 2018 | 1717 | 0.150 |
Why?
|
| Episiotomy | 4 | 2013 | 17 | 0.150 |
Why?
|
| Cross-Over Studies | 2 | 2017 | 330 | 0.150 |
Why?
|
| Hematoma, Subdural | 1 | 2018 | 25 | 0.150 |
Why?
|
| SMARCB1 Protein | 1 | 2018 | 48 | 0.150 |
Why?
|
| Fetal Weight | 1 | 2019 | 72 | 0.150 |
Why?
|
| Intracranial Arteriovenous Malformations | 2 | 2009 | 33 | 0.150 |
Why?
|
| Equipment Design | 3 | 2016 | 604 | 0.150 |
Why?
|
| Placenta Diseases | 1 | 2019 | 60 | 0.150 |
Why?
|
| Umbilical Arteries | 1 | 2019 | 98 | 0.150 |
Why?
|
| Intestinal Diseases | 1 | 2019 | 87 | 0.150 |
Why?
|
| Movement Disorders | 1 | 2021 | 226 | 0.150 |
Why?
|
| Embolization, Therapeutic | 2 | 2012 | 225 | 0.150 |
Why?
|
| Amniotic Fluid | 1 | 2019 | 154 | 0.150 |
Why?
|
| Meningocele | 1 | 2018 | 18 | 0.150 |
Why?
|
| Primary Health Care | 2 | 2018 | 803 | 0.150 |
Why?
|
| Education, Medical | 1 | 2022 | 301 | 0.150 |
Why?
|
| National Institute of Diabetes and Digestive and Kidney Diseases (U.S.) | 2 | 2014 | 8 | 0.150 |
Why?
|
| Placenta | 2 | 2020 | 535 | 0.140 |
Why?
|
| Memory, Short-Term | 1 | 2019 | 148 | 0.140 |
Why?
|
| Ultrasonography, Doppler | 1 | 2019 | 198 | 0.140 |
Why?
|
| Protons | 3 | 2023 | 98 | 0.140 |
Why?
|
| Health Care Costs | 3 | 2011 | 406 | 0.140 |
Why?
|
| Parasympatholytics | 1 | 2017 | 10 | 0.140 |
Why?
|
| Teratoma | 1 | 2018 | 130 | 0.140 |
Why?
|
| Fetal Development | 1 | 2019 | 135 | 0.140 |
Why?
|
| Texas | 6 | 2024 | 3701 | 0.140 |
Why?
|
| Nitroprusside | 1 | 2017 | 42 | 0.140 |
Why?
|
| Patient Admission | 1 | 2018 | 190 | 0.140 |
Why?
|
| Automation | 1 | 2017 | 62 | 0.140 |
Why?
|
| Intracranial Hemorrhages | 2 | 2020 | 81 | 0.140 |
Why?
|
| Colon, Descending | 1 | 2017 | 3 | 0.140 |
Why?
|
| Puerperal Disorders | 2 | 2007 | 47 | 0.140 |
Why?
|
| Gastric Fundus | 1 | 2017 | 9 | 0.140 |
Why?
|
| Insufflation | 1 | 2017 | 19 | 0.140 |
Why?
|
| Age Distribution | 3 | 2020 | 444 | 0.130 |
Why?
|
| Prenatal Diagnosis | 4 | 2023 | 629 | 0.130 |
Why?
|
| Pleural Effusion | 2 | 2015 | 109 | 0.130 |
Why?
|
| Diagnostic Self Evaluation | 1 | 2017 | 23 | 0.130 |
Why?
|
| Cognition Disorders | 2 | 2019 | 579 | 0.130 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2017 | 51 | 0.130 |
Why?
|
| Length of Stay | 6 | 2024 | 1387 | 0.130 |
Why?
|
| Fetal Therapies | 3 | 2025 | 83 | 0.130 |
Why?
|
| Urinary Bladder | 2 | 2017 | 253 | 0.130 |
Why?
|
| Sensitivity and Specificity | 5 | 2021 | 2166 | 0.130 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2023 | 1313 | 0.130 |
Why?
|
| Pressure | 5 | 2021 | 136 | 0.130 |
Why?
|
| Telephone | 1 | 2017 | 127 | 0.130 |
Why?
|
| Vasodilation | 1 | 2017 | 181 | 0.130 |
Why?
|
| Case-Control Studies | 8 | 2021 | 3654 | 0.130 |
Why?
|
| Emergency Medical Services | 2 | 2011 | 414 | 0.130 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2018 | 227 | 0.130 |
Why?
|
| Postmenopause | 1 | 2017 | 155 | 0.130 |
Why?
|
| Critical Pathways | 2 | 2010 | 79 | 0.130 |
Why?
|
| New Zealand | 1 | 2016 | 61 | 0.130 |
Why?
|
| Swine | 2 | 2017 | 1216 | 0.120 |
Why?
|
| Psychometrics | 3 | 2021 | 689 | 0.120 |
Why?
|
| Arm Injuries | 1 | 2015 | 15 | 0.120 |
Why?
|
| Brain Concussion | 1 | 2018 | 236 | 0.120 |
Why?
|
| Latin America | 1 | 2016 | 99 | 0.120 |
Why?
|
| Anesthesiology | 1 | 2017 | 99 | 0.120 |
Why?
|
| Africa | 1 | 2016 | 142 | 0.120 |
Why?
|
| Patient Education as Topic | 4 | 2019 | 466 | 0.120 |
Why?
|
| Australia | 1 | 2016 | 186 | 0.120 |
Why?
|
| Intergenerational Relations | 1 | 2015 | 8 | 0.120 |
Why?
|
| Hypotension | 1 | 2017 | 190 | 0.120 |
Why?
|
| Simulation Training | 1 | 2018 | 146 | 0.120 |
Why?
|
| Emotions | 2 | 2024 | 364 | 0.120 |
Why?
|
| Quality Improvement | 3 | 2022 | 693 | 0.120 |
Why?
|
| Cost of Illness | 2 | 2015 | 276 | 0.120 |
Why?
|
| Washington | 2 | 2016 | 35 | 0.120 |
Why?
|
| Diet | 2 | 2022 | 1191 | 0.120 |
Why?
|
| Chronic Disease | 5 | 2011 | 1255 | 0.120 |
Why?
|
| Nutrition Surveys | 2 | 2015 | 312 | 0.120 |
Why?
|
| Dysmenorrhea | 1 | 1994 | 15 | 0.120 |
Why?
|
| Evidence-Based Medicine | 2 | 2017 | 680 | 0.120 |
Why?
|
| Image Processing, Computer-Assisted | 4 | 2012 | 615 | 0.120 |
Why?
|
| Europe | 1 | 2016 | 380 | 0.110 |
Why?
|
| Comorbidity | 6 | 2022 | 1624 | 0.110 |
Why?
|
| Antigens, CD1d | 1 | 2014 | 21 | 0.110 |
Why?
|
| Cautery | 1 | 2014 | 6 | 0.110 |
Why?
|
| Multicenter Studies as Topic | 3 | 2023 | 291 | 0.110 |
Why?
|
| Checklist | 1 | 2015 | 95 | 0.110 |
Why?
|
| Encopresis | 1 | 1994 | 1 | 0.110 |
Why?
|
| Proton Pump Inhibitors | 1 | 2017 | 284 | 0.110 |
Why?
|
| Models, Psychological | 1 | 2015 | 145 | 0.110 |
Why?
|
| Skull Neoplasms | 1 | 2014 | 16 | 0.110 |
Why?
|
| North Carolina | 1 | 2014 | 64 | 0.110 |
Why?
|
| Algorithms | 3 | 2017 | 1734 | 0.110 |
Why?
|
| Catheter-Related Infections | 1 | 2015 | 134 | 0.110 |
Why?
|
| Placebo Effect | 1 | 2014 | 39 | 0.110 |
Why?
|
| Diabetes Complications | 1 | 2015 | 206 | 0.110 |
Why?
|
| Muscle Contraction | 3 | 1991 | 195 | 0.110 |
Why?
|
| Sample Size | 1 | 2013 | 88 | 0.100 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 1 | 2014 | 96 | 0.100 |
Why?
|
| Thoracic Surgery, Video-Assisted | 2 | 2011 | 57 | 0.100 |
Why?
|
| Cerebral Cortex | 2 | 2014 | 482 | 0.100 |
Why?
|
| Double-Blind Method | 2 | 2015 | 1659 | 0.100 |
Why?
|
| Natural Killer T-Cells | 1 | 2014 | 84 | 0.100 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2013 | 35 | 0.100 |
Why?
|
| Survivors | 3 | 2022 | 358 | 0.100 |
Why?
|
| Diagnosis, Differential | 3 | 2014 | 1974 | 0.100 |
Why?
|
| Activities of Daily Living | 1 | 2015 | 432 | 0.100 |
Why?
|
| Disease-Free Survival | 4 | 2017 | 972 | 0.100 |
Why?
|
| Internal Fixators | 1 | 2012 | 12 | 0.100 |
Why?
|
| Swine, Miniature | 1 | 1992 | 53 | 0.100 |
Why?
|
| Fasting | 1 | 2014 | 306 | 0.100 |
Why?
|
| Statistics, Nonparametric | 4 | 2021 | 454 | 0.100 |
Why?
|
| Arthrodesis | 1 | 2012 | 14 | 0.100 |
Why?
|
| Endovascular Procedures | 1 | 2021 | 775 | 0.100 |
Why?
|
| Aneurysm, Ruptured | 1 | 2012 | 36 | 0.100 |
Why?
|
| Exercise | 1 | 2018 | 869 | 0.100 |
Why?
|
| Tretinoin | 2 | 2003 | 118 | 0.100 |
Why?
|
| Mass Screening | 1 | 2018 | 836 | 0.100 |
Why?
|
| Tuberculosis, Spinal | 1 | 2012 | 9 | 0.100 |
Why?
|
| Spinal Diseases | 1 | 2012 | 46 | 0.100 |
Why?
|
| Psychophysiologic Disorders | 1 | 1992 | 25 | 0.100 |
Why?
|
| Trichomonas Vaginitis | 1 | 1992 | 14 | 0.100 |
Why?
|
| Analgesics, Opioid | 3 | 2022 | 460 | 0.090 |
Why?
|
| Sympathectomy | 1 | 2011 | 8 | 0.090 |
Why?
|
| Health Maintenance Organizations | 2 | 2010 | 24 | 0.090 |
Why?
|
| Osteoblastoma | 1 | 2011 | 3 | 0.090 |
Why?
|
| Cytokines | 1 | 2018 | 1397 | 0.090 |
Why?
|
| Life Change Events | 1 | 1992 | 65 | 0.090 |
Why?
|
| Bulimia | 1 | 1991 | 15 | 0.090 |
Why?
|
| Anorexia Nervosa | 1 | 1991 | 25 | 0.090 |
Why?
|
| Intracranial Aneurysm | 1 | 2012 | 84 | 0.090 |
Why?
|
| Germ-Line Mutation | 1 | 2014 | 369 | 0.090 |
Why?
|
| Educational Status | 1 | 2013 | 298 | 0.090 |
Why?
|
| Staphylococcus aureus | 3 | 2019 | 480 | 0.090 |
Why?
|
| Drug Administration Schedule | 4 | 2015 | 755 | 0.090 |
Why?
|
| Amenorrhea | 1 | 2011 | 21 | 0.090 |
Why?
|
| Neoplastic Stem Cells | 1 | 2014 | 352 | 0.090 |
Why?
|
| Health Care Surveys | 1 | 2012 | 294 | 0.090 |
Why?
|
| Posters as Topic | 1 | 2011 | 7 | 0.090 |
Why?
|
| Patient Satisfaction | 3 | 2017 | 484 | 0.090 |
Why?
|
| Hedgehog Proteins | 1 | 2013 | 266 | 0.090 |
Why?
|
| Cauda Equina | 1 | 2011 | 10 | 0.090 |
Why?
|
| Postpartum Period | 3 | 2007 | 229 | 0.090 |
Why?
|
| Self-Help Groups | 1 | 2011 | 17 | 0.090 |
Why?
|
| Nervous System Diseases | 2 | 2013 | 412 | 0.090 |
Why?
|
| Publications | 1 | 2011 | 35 | 0.090 |
Why?
|
| Thoracoscopy | 1 | 2011 | 43 | 0.090 |
Why?
|
| Gases | 1 | 1991 | 20 | 0.090 |
Why?
|
| Urinary Incontinence, Stress | 3 | 2007 | 32 | 0.090 |
Why?
|
| Intervertebral Disc Displacement | 1 | 2011 | 18 | 0.090 |
Why?
|
| Diskectomy | 1 | 2011 | 13 | 0.090 |
Why?
|
| Metronidazole | 1 | 1992 | 156 | 0.090 |
Why?
|
| Peer Review, Research | 1 | 2011 | 46 | 0.090 |
Why?
|
| Fracture Fixation | 1 | 2011 | 28 | 0.090 |
Why?
|
| Biomarkers | 1 | 2021 | 3430 | 0.090 |
Why?
|
| Skull | 2 | 2012 | 146 | 0.090 |
Why?
|
| Intelligence Tests | 2 | 2022 | 63 | 0.090 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2013 | 233 | 0.090 |
Why?
|
| Device Removal | 2 | 2018 | 221 | 0.090 |
Why?
|
| Evoked Potentials, Motor | 1 | 2011 | 37 | 0.090 |
Why?
|
| Colonic Diseases | 2 | 2006 | 38 | 0.090 |
Why?
|
| Osteosarcoma | 1 | 2014 | 263 | 0.090 |
Why?
|
| Hypertensive Encephalopathy | 1 | 2010 | 5 | 0.090 |
Why?
|
| Long QT Syndrome | 1 | 2011 | 85 | 0.090 |
Why?
|
| Cesarean Section | 4 | 2019 | 400 | 0.090 |
Why?
|
| Heart Diseases | 1 | 2015 | 522 | 0.090 |
Why?
|
| Recovery of Function | 2 | 2010 | 465 | 0.090 |
Why?
|
| Sutures | 1 | 2011 | 66 | 0.090 |
Why?
|
| Interviews as Topic | 2 | 2010 | 418 | 0.090 |
Why?
|
| Vein of Galen Malformations | 1 | 2010 | 7 | 0.090 |
Why?
|
| Geriatric Nursing | 1 | 2010 | 4 | 0.090 |
Why?
|
| Probability | 2 | 2009 | 335 | 0.090 |
Why?
|
| Colon, Sigmoid | 1 | 1990 | 14 | 0.080 |
Why?
|
| Staphylococcal Infections | 3 | 2019 | 573 | 0.080 |
Why?
|
| Physicians | 1 | 2017 | 635 | 0.080 |
Why?
|
| Posterior Leukoencephalopathy Syndrome | 1 | 2010 | 23 | 0.080 |
Why?
|
| Monitoring, Intraoperative | 1 | 2011 | 134 | 0.080 |
Why?
|
| Flatulence | 4 | 2006 | 7 | 0.080 |
Why?
|
| Subarachnoid Space | 1 | 2010 | 25 | 0.080 |
Why?
|
| Respiratory Tract Fistula | 1 | 2010 | 16 | 0.080 |
Why?
|
| Menstruation | 1 | 1990 | 30 | 0.080 |
Why?
|
| Hospitalization | 3 | 2024 | 1899 | 0.080 |
Why?
|
| Congresses as Topic | 1 | 2011 | 187 | 0.080 |
Why?
|
| Polyesters | 1 | 2010 | 43 | 0.080 |
Why?
|
| Pleural Diseases | 1 | 2010 | 31 | 0.080 |
Why?
|
| Organ Size | 2 | 2021 | 467 | 0.080 |
Why?
|
| Pregnancy Trimester, Second | 2 | 2021 | 170 | 0.080 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2011 | 138 | 0.080 |
Why?
|
| Radiotherapy, Adjuvant | 2 | 2023 | 168 | 0.080 |
Why?
|
| Macrophages | 1 | 2014 | 703 | 0.080 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2010 | 130 | 0.080 |
Why?
|
| Suicide, Attempted | 1 | 2011 | 154 | 0.080 |
Why?
|
| Lacerations | 2 | 2007 | 33 | 0.080 |
Why?
|
| Prosthesis Failure | 1 | 2010 | 162 | 0.080 |
Why?
|
| Health Behavior | 2 | 1991 | 404 | 0.080 |
Why?
|
| Neuropsychological Tests | 2 | 2024 | 987 | 0.080 |
Why?
|
| Behavior, Animal | 1 | 1992 | 522 | 0.080 |
Why?
|
| Hematoma, Epidural, Spinal | 1 | 2009 | 7 | 0.080 |
Why?
|
| Pelvic Organ Prolapse | 1 | 2009 | 29 | 0.080 |
Why?
|
| Dilatation | 3 | 2017 | 71 | 0.080 |
Why?
|
| Gastrointestinal Agents | 1 | 2010 | 67 | 0.080 |
Why?
|
| Nerve Sheath Neoplasms | 1 | 2009 | 24 | 0.080 |
Why?
|
| Intraoperative Complications | 1 | 2010 | 163 | 0.080 |
Why?
|
| Neuroendoscopes | 1 | 2009 | 2 | 0.080 |
Why?
|
| Thoracotomy | 1 | 2010 | 112 | 0.080 |
Why?
|
| Laminectomy | 1 | 2009 | 24 | 0.080 |
Why?
|
| Chondroma | 1 | 2009 | 6 | 0.080 |
Why?
|
| Uterine Cervical Neoplasms | 2 | 2003 | 267 | 0.080 |
Why?
|
| Health | 1 | 1989 | 38 | 0.080 |
Why?
|
| Postoperative Period | 2 | 2020 | 343 | 0.080 |
Why?
|
| Heart Defects, Congenital | 1 | 2021 | 1875 | 0.080 |
Why?
|
| Social Environment | 1 | 2009 | 124 | 0.080 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2015 | 904 | 0.080 |
Why?
|
| Arteriovenous Malformations | 1 | 2009 | 47 | 0.080 |
Why?
|
| Ophthalmoplegia | 1 | 2009 | 58 | 0.080 |
Why?
|
| Patient Selection | 2 | 2014 | 734 | 0.080 |
Why?
|
| Electric Stimulation Therapy | 1 | 2010 | 109 | 0.080 |
Why?
|
| Risk Reduction Behavior | 1 | 2010 | 149 | 0.080 |
Why?
|
| Radiotherapy Dosage | 2 | 2023 | 231 | 0.080 |
Why?
|
| Fasciitis | 1 | 2008 | 20 | 0.080 |
Why?
|
| Neurotic Disorders | 3 | 1994 | 6 | 0.080 |
Why?
|
| Joint Dislocations | 1 | 2008 | 24 | 0.080 |
Why?
|
| Confidence Intervals | 1 | 2009 | 300 | 0.070 |
Why?
|
| Spinal Cord Neoplasms | 1 | 2009 | 72 | 0.070 |
Why?
|
| Learning | 1 | 1992 | 374 | 0.070 |
Why?
|
| Periosteum | 1 | 2009 | 33 | 0.070 |
Why?
|
| Carotid Artery Injuries | 1 | 2008 | 38 | 0.070 |
Why?
|
| Suicidal Ideation | 1 | 2011 | 251 | 0.070 |
Why?
|
| Occipital Lobe | 1 | 2008 | 34 | 0.070 |
Why?
|
| Spinal Puncture | 1 | 2008 | 53 | 0.070 |
Why?
|
| Muscles | 1 | 1989 | 306 | 0.070 |
Why?
|
| Oxygen | 1 | 1992 | 582 | 0.070 |
Why?
|
| Radiography, Thoracic | 1 | 2008 | 152 | 0.070 |
Why?
|
| Pneumothorax | 1 | 2008 | 82 | 0.070 |
Why?
|
| Labor, Obstetric | 2 | 2018 | 96 | 0.070 |
Why?
|
| Combined Modality Therapy | 3 | 2010 | 1309 | 0.070 |
Why?
|
| Transforming Growth Factor beta | 1 | 2010 | 484 | 0.070 |
Why?
|
| Infant, Very Low Birth Weight | 1 | 2009 | 178 | 0.070 |
Why?
|
| Sweden | 2 | 2018 | 57 | 0.070 |
Why?
|
| Cognition | 2 | 2023 | 815 | 0.070 |
Why?
|
| Ileus | 1 | 2007 | 10 | 0.070 |
Why?
|
| Scleroderma, Systemic | 1 | 1989 | 119 | 0.070 |
Why?
|
| Sacrum | 1 | 2007 | 34 | 0.070 |
Why?
|
| Desipramine | 1 | 2007 | 27 | 0.070 |
Why?
|
| DNA, Viral | 3 | 2003 | 500 | 0.070 |
Why?
|
| Diazepam | 1 | 2007 | 22 | 0.070 |
Why?
|
| Learning Curve | 2 | 2020 | 57 | 0.070 |
Why?
|
| Adrenergic Uptake Inhibitors | 1 | 2007 | 29 | 0.070 |
Why?
|
| Muscle Relaxants, Central | 1 | 2007 | 39 | 0.070 |
Why?
|
| Muscle Weakness | 2 | 2013 | 94 | 0.070 |
Why?
|
| Recombinant Proteins | 1 | 2010 | 1439 | 0.070 |
Why?
|
| Intestines | 1 | 1991 | 615 | 0.070 |
Why?
|
| Psychotherapy | 1 | 2009 | 246 | 0.070 |
Why?
|
| Imaging, Three-Dimensional | 3 | 2021 | 396 | 0.060 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2003 | 873 | 0.060 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2014 | 1352 | 0.060 |
Why?
|
| Clinical Trials as Topic | 2 | 2013 | 1153 | 0.060 |
Why?
|
| Radiation Injuries | 2 | 2019 | 166 | 0.060 |
Why?
|
| Gynecologic Surgical Procedures | 1 | 2006 | 62 | 0.060 |
Why?
|
| Glasgow Coma Scale | 2 | 2018 | 200 | 0.060 |
Why?
|
| DNA-Binding Proteins | 3 | 2003 | 2166 | 0.060 |
Why?
|
| Reference Values | 2 | 2021 | 742 | 0.060 |
Why?
|
| North America | 2 | 2017 | 260 | 0.060 |
Why?
|
| Nose Neoplasms | 1 | 2005 | 34 | 0.060 |
Why?
|
| Drainage | 2 | 2018 | 265 | 0.060 |
Why?
|
| Osteotomy | 1 | 2005 | 42 | 0.060 |
Why?
|
| Patient Positioning | 2 | 2018 | 57 | 0.060 |
Why?
|
| Dermoid Cyst | 1 | 2005 | 34 | 0.060 |
Why?
|
| Self Report | 2 | 2018 | 553 | 0.060 |
Why?
|
| Aging | 2 | 2023 | 1301 | 0.060 |
Why?
|
| Pinealoma | 1 | 2024 | 23 | 0.060 |
Why?
|
| Cluster Analysis | 2 | 2021 | 440 | 0.050 |
Why?
|
| Child Health Services | 1 | 2004 | 88 | 0.050 |
Why?
|
| Family Health | 1 | 2004 | 268 | 0.050 |
Why?
|
| Abdomen | 2 | 2023 | 136 | 0.050 |
Why?
|
| Sex Offenses | 1 | 2004 | 48 | 0.050 |
Why?
|
| Heart-Assist Devices | 1 | 2012 | 1094 | 0.050 |
Why?
|
| Phosphoproteins | 2 | 2003 | 458 | 0.050 |
Why?
|
| Turkey | 1 | 2023 | 64 | 0.050 |
Why?
|
| Muscle, Smooth | 1 | 2003 | 138 | 0.050 |
Why?
|
| Self Care | 2 | 2015 | 224 | 0.050 |
Why?
|
| Personality Inventory | 2 | 1994 | 176 | 0.050 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2011 | 1159 | 0.050 |
Why?
|
| Cathartics | 2 | 2015 | 31 | 0.050 |
Why?
|
| Antineoplastic Agents | 2 | 2003 | 1850 | 0.050 |
Why?
|
| Societies, Medical | 2 | 2021 | 775 | 0.050 |
Why?
|
| Ascomycota | 1 | 2022 | 26 | 0.050 |
Why?
|
| Cervix Uteri | 1 | 2023 | 64 | 0.050 |
Why?
|
| Cyclins | 1 | 2003 | 105 | 0.050 |
Why?
|
| Population Surveillance | 1 | 2005 | 419 | 0.050 |
Why?
|
| Microarray Analysis | 1 | 2023 | 239 | 0.050 |
Why?
|
| Verbal Learning | 1 | 2022 | 72 | 0.050 |
Why?
|
| Japan | 2 | 2014 | 155 | 0.050 |
Why?
|
| Amphotericin B | 1 | 2022 | 91 | 0.050 |
Why?
|
| China | 1 | 2023 | 294 | 0.050 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2023 | 134 | 0.050 |
Why?
|
| Uterus | 2 | 2019 | 585 | 0.050 |
Why?
|
| Cranial Fossa, Posterior | 1 | 2022 | 20 | 0.050 |
Why?
|
| Antidepressive Agents | 2 | 2018 | 325 | 0.050 |
Why?
|
| Safety | 2 | 2014 | 217 | 0.050 |
Why?
|
| Papillomaviridae | 1 | 2003 | 190 | 0.050 |
Why?
|
| Gram-Negative Facultatively Anaerobic Rods | 1 | 2001 | 1 | 0.050 |
Why?
|
| Drinking | 2 | 2014 | 35 | 0.050 |
Why?
|
| Physician-Patient Relations | 1 | 2006 | 448 | 0.050 |
Why?
|
| Diet, Gluten-Free | 1 | 2021 | 4 | 0.050 |
Why?
|
| Heart Atria | 1 | 2024 | 337 | 0.050 |
Why?
|
| Fetal Movement | 1 | 2021 | 14 | 0.050 |
Why?
|
| Cesarean Section, Repeat | 1 | 2021 | 8 | 0.050 |
Why?
|
| Rewarming | 1 | 2021 | 12 | 0.050 |
Why?
|
| Staphylococcus epidermidis | 1 | 2001 | 40 | 0.050 |
Why?
|
| Cerebrospinal Fluid Proteins | 1 | 2021 | 22 | 0.050 |
Why?
|
| Perineum | 2 | 2006 | 48 | 0.050 |
Why?
|
| Clubfoot | 1 | 2021 | 21 | 0.050 |
Why?
|
| Facial Pain | 1 | 2021 | 8 | 0.050 |
Why?
|
| Neural Cell Adhesion Molecule L1 | 1 | 2021 | 6 | 0.050 |
Why?
|
| Mastoidectomy | 1 | 2021 | 6 | 0.050 |
Why?
|
| Viral Proteins | 1 | 2003 | 360 | 0.040 |
Why?
|
| Surgical Instruments | 1 | 2021 | 57 | 0.040 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2003 | 321 | 0.040 |
Why?
|
| Slit Ventricle Syndrome | 1 | 2020 | 2 | 0.040 |
Why?
|
| Prolactinoma | 1 | 2001 | 4 | 0.040 |
Why?
|
| Obesity | 1 | 2013 | 2433 | 0.040 |
Why?
|
| Labor, Induced | 1 | 2021 | 34 | 0.040 |
Why?
|
| Encephalocele | 1 | 2021 | 48 | 0.040 |
Why?
|
| Hospital Charges | 1 | 2021 | 63 | 0.040 |
Why?
|
| Animals | 4 | 2017 | 36443 | 0.040 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2022 | 251 | 0.040 |
Why?
|
| Health Services Accessibility | 2 | 2021 | 648 | 0.040 |
Why?
|
| Transplants | 1 | 2021 | 37 | 0.040 |
Why?
|
| Preoperative Period | 1 | 2020 | 93 | 0.040 |
Why?
|
| Healthy Volunteers | 1 | 2021 | 153 | 0.040 |
Why?
|
| Insurance Coverage | 1 | 2021 | 124 | 0.040 |
Why?
|
| Central Nervous System | 1 | 2022 | 286 | 0.040 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 1 | 2021 | 82 | 0.040 |
Why?
|
| Transplantation, Autologous | 1 | 2021 | 285 | 0.040 |
Why?
|
| Temperature | 1 | 2021 | 329 | 0.040 |
Why?
|
| Transplantation, Heterologous | 1 | 2021 | 275 | 0.040 |
Why?
|
| Abortion, Spontaneous | 1 | 2021 | 85 | 0.040 |
Why?
|
| Headache | 1 | 2001 | 110 | 0.040 |
Why?
|
| Mutation | 1 | 2014 | 6295 | 0.040 |
Why?
|
| Antifungal Agents | 1 | 2022 | 306 | 0.040 |
Why?
|
| Uterine Contraction | 1 | 2019 | 29 | 0.040 |
Why?
|
| Vancomycin | 1 | 2022 | 236 | 0.040 |
Why?
|
| Pulsatile Flow | 1 | 2020 | 128 | 0.040 |
Why?
|
| Lactose Intolerance | 2 | 1990 | 12 | 0.040 |
Why?
|
| Hepatitis B Core Antigens | 1 | 1999 | 14 | 0.040 |
Why?
|
| Propionibacterium acnes | 1 | 2019 | 14 | 0.040 |
Why?
|
| Data Collection | 1 | 2001 | 398 | 0.040 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 2020 | 64 | 0.040 |
Why?
|
| Codon | 1 | 1999 | 109 | 0.040 |
Why?
|
| Virus Assembly | 1 | 1999 | 47 | 0.040 |
Why?
|
| DNA, Single-Stranded | 1 | 1999 | 76 | 0.040 |
Why?
|
| Intraoperative Period | 1 | 2019 | 74 | 0.040 |
Why?
|
| Risk | 1 | 2021 | 835 | 0.040 |
Why?
|
| Umbilical Veins | 1 | 2019 | 73 | 0.040 |
Why?
|
| Sex Characteristics | 1 | 2021 | 335 | 0.040 |
Why?
|
| Remission, Spontaneous | 1 | 2018 | 69 | 0.040 |
Why?
|
| Perioperative Care | 1 | 2021 | 210 | 0.040 |
Why?
|
| Postnatal Care | 1 | 2019 | 52 | 0.040 |
Why?
|
| Ribs | 1 | 2019 | 54 | 0.040 |
Why?
|
| Workflow | 1 | 2019 | 134 | 0.040 |
Why?
|
| Portal Vein | 1 | 2019 | 95 | 0.040 |
Why?
|
| Electronic Mail | 1 | 2018 | 43 | 0.040 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2001 | 833 | 0.040 |
Why?
|
| Iron | 1 | 2021 | 305 | 0.040 |
Why?
|
| Hepatitis B virus | 1 | 1999 | 142 | 0.040 |
Why?
|
| Oxytocics | 1 | 2018 | 27 | 0.040 |
Why?
|
| Trial of Labor | 1 | 2018 | 22 | 0.040 |
Why?
|
| Iatrogenic Disease | 1 | 2019 | 132 | 0.040 |
Why?
|
| Health Education | 1 | 2020 | 228 | 0.040 |
Why?
|
| Heart Rate | 1 | 2021 | 599 | 0.040 |
Why?
|
| Personality | 2 | 1990 | 115 | 0.040 |
Why?
|
| Patient Compliance | 1 | 2021 | 479 | 0.040 |
Why?
|
| Urodynamics | 1 | 2017 | 40 | 0.040 |
Why?
|
| Cold Temperature | 1 | 2018 | 86 | 0.040 |
Why?
|
| Meningitis | 1 | 2018 | 101 | 0.040 |
Why?
|
| Oxytocin | 1 | 2018 | 73 | 0.040 |
Why?
|
| Cannabis | 1 | 2018 | 52 | 0.030 |
Why?
|
| Sickness Impact Profile | 2 | 2007 | 39 | 0.030 |
Why?
|
| Contrast Media | 1 | 2021 | 513 | 0.030 |
Why?
|
| Translating | 1 | 2017 | 31 | 0.030 |
Why?
|
| Transcription, Genetic | 3 | 2003 | 1758 | 0.030 |
Why?
|
| Spinal Cord | 2 | 2009 | 319 | 0.030 |
Why?
|
| Program Evaluation | 1 | 2019 | 453 | 0.030 |
Why?
|
| Birth Weight | 1 | 2019 | 352 | 0.030 |
Why?
|
| Magnetic Resonance Angiography | 2 | 2012 | 168 | 0.030 |
Why?
|
| Models, Anatomic | 1 | 2018 | 104 | 0.030 |
Why?
|
| Comparative Effectiveness Research | 1 | 2017 | 76 | 0.030 |
Why?
|
| Parity | 2 | 2007 | 88 | 0.030 |
Why?
|
| Maternal Exposure | 1 | 2018 | 154 | 0.030 |
Why?
|
| Visual Acuity | 1 | 2001 | 708 | 0.030 |
Why?
|
| Infant, Low Birth Weight | 1 | 2017 | 176 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2021 | 1243 | 0.030 |
Why?
|
| Eating | 1 | 2018 | 394 | 0.030 |
Why?
|
| Social Isolation | 1 | 2015 | 48 | 0.030 |
Why?
|
| Arm | 1 | 2015 | 81 | 0.030 |
Why?
|
| Energy Metabolism | 1 | 2020 | 813 | 0.030 |
Why?
|
| Biopsy | 2 | 2009 | 1302 | 0.030 |
Why?
|
| Mitochondria | 1 | 2020 | 744 | 0.030 |
Why?
|
| Dinoprost | 1 | 1994 | 30 | 0.030 |
Why?
|
| Mothers | 1 | 2018 | 369 | 0.030 |
Why?
|
| Anxiety Disorders | 1 | 2021 | 733 | 0.030 |
Why?
|
| Placebos | 1 | 1995 | 241 | 0.030 |
Why?
|
| Cerebral Aqueduct | 1 | 2014 | 11 | 0.030 |
Why?
|
| Single-Blind Method | 1 | 1995 | 250 | 0.030 |
Why?
|
| Computer Simulation | 1 | 2018 | 708 | 0.030 |
Why?
|
| Intensive Care Units, Pediatric | 1 | 2018 | 485 | 0.030 |
Why?
|
| Mutation, Missense | 1 | 1999 | 932 | 0.030 |
Why?
|
| Oncogene Protein v-akt | 1 | 2014 | 33 | 0.030 |
Why?
|
| Brain Stem | 1 | 2015 | 121 | 0.030 |
Why?
|
| Pain Management | 1 | 2016 | 199 | 0.030 |
Why?
|
| Aerophagy | 1 | 1994 | 1 | 0.030 |
Why?
|
| Feasibility Studies | 2 | 2011 | 817 | 0.030 |
Why?
|
| Disease Management | 1 | 2018 | 564 | 0.030 |
Why?
|
| Echocardiography | 1 | 2020 | 1129 | 0.030 |
Why?
|
| Education | 1 | 2014 | 111 | 0.030 |
Why?
|
| Drinking Water | 1 | 2014 | 17 | 0.030 |
Why?
|
| Dinoprostone | 1 | 1994 | 82 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2014 | 65 | 0.030 |
Why?
|
| Immunoenzyme Techniques | 1 | 2014 | 258 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2017 | 1199 | 0.030 |
Why?
|
| Poaceae | 1 | 1993 | 15 | 0.030 |
Why?
|
| Paresis | 1 | 2013 | 34 | 0.030 |
Why?
|
| Animal Feed | 1 | 1993 | 83 | 0.030 |
Why?
|
| ras Proteins | 1 | 2014 | 146 | 0.030 |
Why?
|
| Genes, gag | 1 | 1993 | 8 | 0.030 |
Why?
|
| DNA, Antisense | 1 | 1993 | 9 | 0.030 |
Why?
|
| RNA, Messenger | 2 | 2014 | 2902 | 0.030 |
Why?
|
| Treatment Failure | 1 | 2014 | 367 | 0.030 |
Why?
|
| Fanconi Anemia | 1 | 2013 | 45 | 0.030 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2016 | 854 | 0.030 |
Why?
|
| Social Support | 1 | 2015 | 378 | 0.030 |
Why?
|
| Interferon Regulatory Factor-1 | 2 | 2003 | 16 | 0.030 |
Why?
|
| Biological Assay | 1 | 1993 | 111 | 0.030 |
Why?
|
| Brain Edema | 1 | 2013 | 71 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2003 | 2715 | 0.030 |
Why?
|
| Endocrine System Diseases | 1 | 2013 | 44 | 0.030 |
Why?
|
| Pregnancy Complications | 1 | 2018 | 550 | 0.030 |
Why?
|
| Pupil | 1 | 2013 | 57 | 0.030 |
Why?
|
| Neurologic Examination | 1 | 2013 | 205 | 0.020 |
Why?
|
| Attitude of Health Personnel | 1 | 2018 | 716 | 0.020 |
Why?
|
| Affective Symptoms | 1 | 2013 | 63 | 0.020 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1993 | 295 | 0.020 |
Why?
|
| Spondylitis | 1 | 2012 | 8 | 0.020 |
Why?
|
| Medical Records | 1 | 2013 | 193 | 0.020 |
Why?
|
| STAT1 Transcription Factor | 2 | 2003 | 78 | 0.020 |
Why?
|
| Menstruation Disturbances | 1 | 1992 | 16 | 0.020 |
Why?
|
| Partial Pressure | 1 | 1992 | 29 | 0.020 |
Why?
|
| Head Protective Devices | 1 | 2012 | 23 | 0.020 |
Why?
|
| Neoplasm Grading | 1 | 2013 | 307 | 0.020 |
Why?
|
| Apnea | 1 | 2012 | 31 | 0.020 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2012 | 71 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2014 | 542 | 0.020 |
Why?
|
| Back Pain | 1 | 2012 | 31 | 0.020 |
Why?
|
| Stellate Ganglion | 1 | 2011 | 10 | 0.020 |
Why?
|
| Ganglia, Sympathetic | 1 | 2011 | 23 | 0.020 |
Why?
|
| Atenolol | 1 | 2011 | 43 | 0.020 |
Why?
|
| Developmental Disabilities | 1 | 2017 | 733 | 0.020 |
Why?
|
| Observer Variation | 1 | 2012 | 313 | 0.020 |
Why?
|
| Lactulose | 1 | 1991 | 43 | 0.020 |
Why?
|
| Maternal Behavior | 1 | 1992 | 71 | 0.020 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2014 | 455 | 0.020 |
Why?
|
| Risk Assessment | 2 | 2017 | 3708 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 1327 | 0.020 |
Why?
|
| MMPI | 1 | 1991 | 16 | 0.020 |
Why?
|
| Adjuvants, Anesthesia | 1 | 2011 | 7 | 0.020 |
Why?
|
| Body Temperature | 1 | 1992 | 130 | 0.020 |
Why?
|
| Disinfection | 1 | 2011 | 29 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2013 | 791 | 0.020 |
Why?
|
| Syncope | 1 | 2011 | 54 | 0.020 |
Why?
|
| Feces | 1 | 1995 | 788 | 0.020 |
Why?
|
| Breath Tests | 1 | 1991 | 186 | 0.020 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 1993 | 243 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2014 | 1006 | 0.020 |
Why?
|
| Absorbable Implants | 1 | 2011 | 28 | 0.020 |
Why?
|
| Pyramidal Tracts | 1 | 2011 | 37 | 0.020 |
Why?
|
| Cell Division | 2 | 2003 | 773 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2014 | 1071 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1992 | 469 | 0.020 |
Why?
|
| Gait | 1 | 2012 | 148 | 0.020 |
Why?
|
| Intracranial Hypertension | 1 | 2012 | 134 | 0.020 |
Why?
|
| Estrogens | 1 | 1993 | 523 | 0.020 |
Why?
|
| Electrophysiology | 2 | 1989 | 282 | 0.020 |
Why?
|
| Vision Disorders | 1 | 2013 | 221 | 0.020 |
Why?
|
| Terminology as Topic | 1 | 2012 | 234 | 0.020 |
Why?
|
| Cross-Cultural Comparison | 1 | 2011 | 59 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 2 | 2003 | 1103 | 0.020 |
Why?
|
| Fentanyl | 1 | 2011 | 54 | 0.020 |
Why?
|
| Brain Ischemia | 1 | 2013 | 278 | 0.020 |
Why?
|
| Minnesota | 1 | 2011 | 181 | 0.020 |
Why?
|
| ROC Curve | 1 | 2012 | 610 | 0.020 |
Why?
|
| Posture | 1 | 1991 | 157 | 0.020 |
Why?
|
| Ice | 1 | 1990 | 5 | 0.020 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2010 | 88 | 0.020 |
Why?
|
| Psychophysiology | 1 | 1990 | 8 | 0.020 |
Why?
|
| Circadian Rhythm | 1 | 1993 | 298 | 0.020 |
Why?
|
| Organizational Policy | 1 | 2010 | 54 | 0.020 |
Why?
|
| Fibrin Tissue Adhesive | 1 | 2010 | 13 | 0.020 |
Why?
|
| Ganglioneuroma | 1 | 2010 | 18 | 0.020 |
Why?
|
| Perfusion | 1 | 1991 | 214 | 0.020 |
Why?
|
| Bone Marrow Transplantation | 1 | 2013 | 619 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2014 | 1388 | 0.020 |
Why?
|
| Electric Stimulation | 1 | 2011 | 326 | 0.020 |
Why?
|
| Maryland | 1 | 1990 | 35 | 0.020 |
Why?
|
| Thoracic Neoplasms | 1 | 2010 | 38 | 0.020 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2011 | 128 | 0.020 |
Why?
|
| Physical Endurance | 1 | 1990 | 48 | 0.020 |
Why?
|
| Organizations | 1 | 2010 | 16 | 0.020 |
Why?
|
| Surgery, Plastic | 1 | 2012 | 105 | 0.020 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2011 | 252 | 0.020 |
Why?
|
| Postoperative Care | 1 | 2012 | 311 | 0.020 |
Why?
|
| Interview, Psychological | 1 | 1990 | 107 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2013 | 1596 | 0.020 |
Why?
|
| Fatal Outcome | 1 | 2010 | 376 | 0.020 |
Why?
|
| Affect | 1 | 1990 | 172 | 0.020 |
Why?
|
| International Cooperation | 1 | 2010 | 169 | 0.020 |
Why?
|
| Defibrillators, Implantable | 1 | 2011 | 198 | 0.020 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2010 | 294 | 0.020 |
Why?
|
| Frail Elderly | 1 | 2010 | 107 | 0.020 |
Why?
|
| Prostheses and Implants | 1 | 2010 | 152 | 0.020 |
Why?
|
| X-Ray Microtomography | 1 | 2009 | 95 | 0.020 |
Why?
|
| Quality Assurance, Health Care | 1 | 2010 | 221 | 0.020 |
Why?
|
| Colposcopy | 1 | 2008 | 15 | 0.020 |
Why?
|
| Trans-Activators | 2 | 2003 | 831 | 0.020 |
Why?
|
| Cerebrovascular Disorders | 1 | 1989 | 126 | 0.020 |
Why?
|
| Life Style | 1 | 1991 | 461 | 0.020 |
Why?
|
| Anthropometry | 1 | 2009 | 205 | 0.020 |
Why?
|
| Patient Dropouts | 1 | 2008 | 52 | 0.020 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2010 | 199 | 0.020 |
Why?
|
| Drug Utilization | 1 | 1989 | 170 | 0.020 |
Why?
|
| Angioplasty | 1 | 2008 | 80 | 0.020 |
Why?
|
| Disease Progression | 1 | 2014 | 2240 | 0.020 |
Why?
|
| Geriatrics | 1 | 1988 | 78 | 0.020 |
Why?
|
| Nurse Practitioners | 1 | 1988 | 50 | 0.020 |
Why?
|
| Surgical Mesh | 1 | 2007 | 70 | 0.020 |
Why?
|
| Focus Groups | 1 | 2008 | 211 | 0.020 |
Why?
|
| Health Status Indicators | 1 | 2007 | 130 | 0.020 |
Why?
|
| Acute Disease | 1 | 2010 | 1191 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2014 | 1919 | 0.020 |
Why?
|
| Internal Medicine | 1 | 1988 | 159 | 0.020 |
Why?
|
| Observation | 1 | 2006 | 45 | 0.020 |
Why?
|
| Ambulatory Care Facilities | 1 | 1988 | 239 | 0.020 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2008 | 284 | 0.020 |
Why?
|
| Diagnostic Imaging | 1 | 2008 | 317 | 0.020 |
Why?
|
| Sexual Behavior | 1 | 2007 | 250 | 0.020 |
Why?
|
| Hospitals, Pediatric | 1 | 2010 | 788 | 0.020 |
Why?
|
| Physical Exertion | 1 | 1985 | 77 | 0.010 |
Why?
|
| Pediatrics | 1 | 2014 | 1210 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1985 | 260 | 0.010 |
Why?
|
| Absenteeism | 1 | 2004 | 19 | 0.010 |
Why?
|
| Stroke | 1 | 2013 | 1074 | 0.010 |
Why?
|
| Domestic Violence | 1 | 2004 | 12 | 0.010 |
Why?
|
| Biomedical Research | 1 | 2010 | 555 | 0.010 |
Why?
|
| 5' Flanking Region | 1 | 2003 | 10 | 0.010 |
Why?
|
| Anticoagulants | 1 | 2008 | 604 | 0.010 |
Why?
|
| Peptide Initiation Factors | 1 | 2003 | 30 | 0.010 |
Why?
|
| Interferon Regulatory Factors | 1 | 2003 | 41 | 0.010 |
Why?
|
| Cell Line, Transformed | 1 | 2003 | 169 | 0.010 |
Why?
|
| Neoplasm Invasiveness | 1 | 2005 | 669 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2003 | 92 | 0.010 |
Why?
|
| Neurons | 1 | 1993 | 2047 | 0.010 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2003 | 89 | 0.010 |
Why?
|
| Oligonucleotides | 1 | 2002 | 93 | 0.010 |
Why?
|
| Defecography | 1 | 2002 | 2 | 0.010 |
Why?
|
| Sampling Studies | 1 | 2002 | 79 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2006 | 1487 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 2005 | 920 | 0.010 |
Why?
|
| Methods | 1 | 1981 | 143 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2014 | 4912 | 0.010 |
Why?
|
| Hypophysectomy | 1 | 2001 | 21 | 0.010 |
Why?
|
| Cues | 1 | 1981 | 100 | 0.010 |
Why?
|
| Interferon-gamma | 1 | 2003 | 538 | 0.010 |
Why?
|
| Transfection | 1 | 2003 | 1092 | 0.010 |
Why?
|
| Pituitary Gland | 1 | 2001 | 88 | 0.010 |
Why?
|
| Imitative Behavior | 1 | 2000 | 6 | 0.010 |
Why?
|
| Binding Sites | 1 | 2003 | 1378 | 0.010 |
Why?
|
| Mice | 2 | 2014 | 18963 | 0.010 |
Why?
|
| NF-kappa B | 1 | 2002 | 482 | 0.010 |
Why?
|
| Databases as Topic | 1 | 2000 | 77 | 0.010 |
Why?
|
| Hepatitis B Surface Antigens | 1 | 1999 | 54 | 0.010 |
Why?
|
| Protein Binding | 1 | 2003 | 1847 | 0.010 |
Why?
|
| Immunoblotting | 1 | 1999 | 318 | 0.010 |
Why?
|
| Virion | 1 | 1999 | 151 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2002 | 1422 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2002 | 1707 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2002 | 2123 | 0.010 |
Why?
|
| Diethylstilbestrol | 1 | 1993 | 140 | 0.010 |
Why?
|
| RNA Probes | 1 | 1993 | 31 | 0.010 |
Why?
|
| Base Composition | 1 | 1993 | 75 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 1993 | 271 | 0.010 |
Why?
|
| Molecular Weight | 1 | 1993 | 388 | 0.010 |
Why?
|
| Brain Chemistry | 1 | 1993 | 125 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 1993 | 485 | 0.010 |
Why?
|
| Encephalitis | 1 | 1993 | 121 | 0.010 |
Why?
|
| Estradiol | 1 | 1993 | 558 | 0.010 |
Why?
|
| HeLa Cells | 1 | 1993 | 834 | 0.010 |
Why?
|
| Phenotype | 1 | 1999 | 4552 | 0.000 |
Why?
|
| Sensory Thresholds | 1 | 1989 | 38 | 0.000 |
Why?
|
| Proprioception | 1 | 1989 | 21 | 0.000 |
Why?
|
| Relaxation Therapy | 1 | 1985 | 17 | 0.000 |
Why?
|
| Mental Status Schedule | 1 | 1985 | 45 | 0.000 |
Why?
|
| Abdominal Muscles | 1 | 1985 | 29 | 0.000 |
Why?
|